UBS AM’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $153M | Buy |
2,933,988
+156,948
| +6% | +$8.17M | 0.03% | 450 |
|
2025
Q1 | $118M | Buy |
2,777,040
+164,263
| +6% | +$7M | 0.03% | 495 |
|
2024
Q4 | $79.8M | Sell |
2,612,777
-731,260
| -22% | -$22.3M | 0.02% | 563 |
|
2024
Q3 | $76.7M | Buy |
3,344,037
+110,993
| +3% | +$2.55M | 0.02% | 580 |
|
2024
Q2 | $93.4M | Buy |
3,233,044
+2,331,011
| +258% | +$67.3M | 0.03% | 477 |
|
2024
Q1 | $18.6M | Buy |
902,033
+265,941
| +42% | +$5.49M | 0.01% | 807 |
|
2023
Q4 | $17.2M | Buy |
636,092
+49,643
| +8% | +$1.34M | 0.01% | 804 |
|
2023
Q3 | $17.4M | Buy |
586,449
+298,172
| +103% | +$8.84M | 0.01% | 792 |
|
2023
Q2 | $6.76M | Hold |
288,277
| – | – | ﹤0.01% | 1107 |
|
2023
Q1 | $6.76M | Buy |
288,277
+3,792
| +1% | +$88.9K | ﹤0.01% | 1107 |
|
2022
Q4 | $7.74M | Buy |
284,485
+146,794
| +107% | +$3.99M | ﹤0.01% | 1027 |
|
2022
Q3 | $7.41M | Sell |
137,691
-22,199
| -14% | -$1.19M | ﹤0.01% | 1061 |
|
2022
Q2 | $6.45M | Sell |
159,890
-81,259
| -34% | -$3.28M | ﹤0.01% | 1120 |
|
2022
Q1 | $16M | Sell |
241,149
-42,884
| -15% | -$2.84M | 0.01% | 909 |
|
2021
Q4 | $28.4M | Buy |
284,033
+37,780
| +15% | +$3.78M | 0.01% | 811 |
|
2021
Q3 | $30.8M | Buy |
246,253
+139,023
| +130% | +$17.4M | 0.01% | 755 |
|
2021
Q2 | $13.3M | Buy |
107,230
+5,692
| +6% | +$707K | 0.01% | 1014 |
|
2021
Q1 | $15.5M | Buy |
101,538
+561
| +0.6% | +$85.6K | 0.01% | 937 |
|
2020
Q4 | $13M | Buy |
100,977
+36,796
| +57% | +$4.74M | 0.01% | 963 |
|
2020
Q3 | $7.17M | Buy |
64,181
+402
| +0.6% | +$44.9K | ﹤0.01% | 1035 |
|
2020
Q2 | $5.17M | Buy |
63,779
+13,673
| +27% | +$1.11M | ﹤0.01% | 1105 |
|
2020
Q1 | $3.49M | Buy |
50,106
+11,757
| +31% | +$818K | ﹤0.01% | 1197 |
|
2019
Q4 | $3M | Sell |
38,349
-4,902
| -11% | -$383K | ﹤0.01% | 1431 |
|
2019
Q3 | $2.76M | Buy |
43,251
+19,718
| +84% | +$1.26M | ﹤0.01% | 1465 |
|
2019
Q2 | $2.03M | Buy |
+23,533
| New | +$2.03M | ﹤0.01% | 1583 |
|